# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000320017-24-000016
Filing Date
2024-04-29
Accepted
2024-04-29 16:51:43
Documents
7
Period of Report
2024-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def14a-20240429.htm | DEF 14A | 871213
2 |  | djmnew.jpg | GRAPHIC | 7742
3 |  | lisata.jpg | GRAPHIC | 16409
4 |  | proxycard-pc4_pagex2a.jpg | GRAPHIC | 527659
5 |  | proxycardfinaltuesday0423a.jpg | GRAPHIC | 533736
6 |  | pvp104042024.jpg | GRAPHIC | 789755
7 |  | pvp204042024.jpg | GRAPHIC | 772621
| Complete submission text file | 0000320017-24-000016.txt |  | 4517331

Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33650 | Film No.: 24892084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)